1,091 results
Page 18 of 55
6-K
EX-99.1
m5eujsyy u700pf
4 Apr 12
Teva Provides Litigation Update
12:00am
6-K
EX-99.1
h2i7ewgrhp
28 Mar 12
Teva Announces Launch of Generic Seroquel® in the United States
12:00am
6-K
EX-99.1
vl0k0ey 45y1
21 Mar 12
Live Filing
12:00am
6-K
EX-99.1
4jef0fmg
16 Mar 12
Live Filing
12:00am
6-K
EX-99.1
f8536
14 Mar 12
Teva Announces Launch of Generic Lexapro® in the United States; Awarded 180-Day Period of Marketing Exclusivity
12:00am
6-K
EX-99.1
xpfg j794oo255aabf16
8 Mar 12
Teva and OncoGenex Announce Updates to Custirsen Development Program in Advanced Prostate Cancer
12:00am
6-K
EX-99.1
kex5 8wb8orq
8 Mar 12
Teva Receives FDA Approval for ProAir® HFA (albuterol sulfate) with Dose Counter
12:00am
6-K
EX-99.1
lrjyijqu5ugb7xrf82
5 Mar 12
Late Stage Data Demonstrated Long-Term Nasal Symptom Relief and Improvement in Quality of Life
12:00am
6-K
EX-99.1
bl5z9i
2 Mar 12
Teva Announces Launch of Generic Prometrium® Capsules in the United States
12:00am
6-K
9wld3x9 0qo69e
15 Feb 12
Teva Pharmaceutical Industries Limited 6-K
12:00am
6-K
EX-99.1
a7pj6mhf5dzoq93
3 Jan 12
Live Filing
12:00am
6-K
EX-99.1
wfd612leqz2bwpza0
3 Jan 12
Teva Announces Management Succession
12:00am
6-K
EX-99.1
1gm39zxwk0xe7djgfv
21 Dec 11
Teva Provides 2012 Non-GAAP Financial Outlook; 2012 Non-GAAP Diluted EPS of $5.48 to $5.68
12:00am
F-3ASR
7hce8v3 gab9
9 Dec 11
Automatic shelf registration (foreign)
12:00am
F-3ASR
EX-5.3
gvmy2iq r0bwnro56z4
9 Dec 11
Automatic shelf registration (foreign)
12:00am
6-K
EX-99.1
m6qjk1y0y
2 Dec 11
Live Filing
12:00am
6-K
EX-99.1
tvt9zq1mkiasj
1 Dec 11
Live Filing
12:00am
6-K
EX-5.3
lakc1
10 Nov 11
Current report (foreign)
12:00am
6-K
EX-99.1
a4nkuhv
8 Nov 11
Teva Announces Pricing of $5,000,000,000 of Senior Notes
12:00am